Singh, Jasvinder, MD, MPH

Singh---2012Professor of Medicine



Address: 
 

Faculty Office Tower, room 805B
Birmingham, AL 35294-0000

Telephone: (205) 934-8158
Email: jassingh@uab.edu

 

 

Education


Bachelor of Medicine and Bachelor of Surgery (MBBS), University College of Medical Sciences, New Delhi, India, 1988-1993
Master of Public Health (Epidemiology), University of Minnesota, Minneapolis, MN, 2001-2003
Residency (Psychiatry), All India Institute of Medical Sciences (AIIMS), New Delhi, India , 1994
Residency (Internal Medicine), State University of New York (SUNY), Syracuse, NY, 1995-1998
Fellowship (Rheumatology), Washington University School of Medicine & Barnes Jewish Hospital, St. Louis, MO, 1998-2001

 

Research Interests


Dr. Singh is involved in performing Cochrane reviews and network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis and other therapies for rheuamtic diseases. He is also conducting studies of patient-reported outcomes in patients with various forms of arthritis, in particular osteoarthritis, joint replacement and gout. He is performing studies of comparative effectiveness of treatments used in patients with gout and joint replacement.

 

Selected Publications


Singh JA. 2015. When gout goes to the heart: does gout equal a cardiovascular disease risk factor? Ann Rheum Dis. 74(4):631-634. PMID: 25603830.


Wang H, et al. 2014. Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.  Lancet. 384: 957-979 . PMID: 24797572; PMCID: PMC4165626


Singh JA, Taylor WJ, Dalbeth N, Simon LS, Sundy J, Grainger R, Alten R, March L, Strand V, Wells G, Khanna D, McQueen F, Schlesinger N, Boonen A, Boers M, Saag KG, Schumacher HR, Edwards NL. 2014. OMERACT endorsement of measures of outcome for studies of acute gout. J Rheumatol. 41(3):569-573. PMID: 24334651; PMCID: PMC4162875


Singh JA, Ramachandran R. 2014. Hospital Volume Predicts Outcomes and Complications after Total Shoulder Arthroplasty in the United States. Arthritis Care Res (Hoboken).  PMID: 25370499.


Singh JA, Luo R, Landon GC, Suarez-Almazor M. 2014. Reliability and clinically important improvement thresholds for osteoarthritis pain and function scales: a multicenter study. J Rheumatol. 41(3):509-515. PMID: 24429183; PMCID: PMC3943561.


Singh JA, Lu X, Rosenthal GE, Ibrahim S, Cram P. 2013. Racial disparities in knee and hip total joint arthroplasty: an 18-year analysis of national medicare data. Ann Rheum Dis. 2013 Sep 18. PMID:24047869


Mudano AS, Gary LC, Oliveira AL, Melton M, Wright NC, Curtis JR, Delzell E, Harrington TM, Kilgore ML, Lewis CE, Singh JA, Warriner AH, Pace WD, Saag KG. 2013. Using tablet computers compared to interactive voice response to improve subject recruitment in osteoporosis pragmatic clinical trials: feasibility, satisfaction, and sample size. Patient Prefer Adherence. 7:517-23. PMID:23807841


Singh JA, Hawn M, Campagna EJ, Henderson WG, Richman J, Houston TK. 2013. Mediation of smoking-associated postoperative mortality by perioperative complications in veterans undergoing elective surgery: data from Veterans Affairs Surgical Quality Improvement Program (VASQIP)--a cohort study. BMJ Open. 2013 Apr 18;3(4). PMID:23604347


Saag KG, Mohr PE, Esmail L, Mudano AS, Wright N, Beukelman T, Curtis JR, Cutter G, Delzell E, Gary LC, Harrington TM, Karkare S, Kilgore ML, Lewis CE, Moloney R, Oliveira A, Singh JA, Warriner A, Zhang J, Berger M, Cummings SR, Pace W, Solomon DH, Wallace R, Tunis SR. 2012. Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States. Contemp Clin Trials. 33(6):1211-6. PMID:22796098


Singh JA, Lewallen DG. 2012. Ninety-day mortality in patients undergoing elective total hip or total knee arthroplasty. J Arthroplasty. 27(8):1417-1422.e1. PMID:22554727


Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, Moreland LW, O'Dell J, Winthrop KL, Beukelman T, Bridges SL Jr, Chatham WW, Paulus HE, Suarez-Almazor M, Bombardier C, Dougados M, Khanna D, King CM, Leong AL, Matteson EL, Schousboe JT, Moynihan E, Kolba KS, Jain A, Volkmann ER, Agrawal H, Bae S, Mudano AS, Patkar NM, Saag KG. 2012. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 64(5):625-39. PMID:22473917


Navarro-Millán I, Singh JA, Curtis JR. 2012.Systematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin-6 receptor. Clin Ther. 2012 Apr;34(4):788-802.e3. PMID:22444783


Singh JA. 2011 Epidemiology of knee and hip arthroplasty: a systematic review. Open Orthop J. 5:80-5. PMID: 21584277


Kalore NV, Gioe TJ, Singh JA. 2011. Diagnosis and management of infected total knee arthroplasty.Open Orthop J. 5:86-91. PMID: 21584272


Singh JA. 2011. Editorial: current concepts in arthroplasty. Open Orthop J. 5:78-9. PMID: 21584271


Mertens MT, Singh JA. 2011. Biomarkers in arthroplasty: a systematic review. Open Orthop J. 2011 5:92-105. PMID: 21584201


Johnson MR, Singh JA, Stewart T, Gioe TJ. 2011. Patient understanding and satisfaction in informed consent for total knee arthroplasty: A randomized study. Arthritis Care Res (Hoboken).63(7):1048-54. PMID: 21485018


Khanna D, Sarkin AJ, Khanna PP, Shieh MM, Kavanaugh AF, Terkeltaub RA, Lee SJ, Singh JA, Hirsch JD. 2011. Minimally important differences of the gout impact scale in a randomized controlled trial.Rheumatology (Oxford). 2011 Mar 3. [Epub ahead of print]PMID: 21372003


Singh JA, Wells GA, Christensen R, Tanjong Ghogomu E, Maxwell L, Macdonald JK, Filippini G, Skoetz N, Francis D, Lopes LC, Guyatt GH, Schmitt J, La Mantia L, Weberschock T, Roos JF, Siebert H, Hershan S, Lunn MP, Tugwell P, Buchbinder R. 2011. Adverse effects of biologics: a network meta-analysis and Cochrane overview. Cochrane Database Syst Rev. 2011 Feb 16;2:CD008794. PMID: 21328309


Singh JA. 2010. Botulinum toxin therapy for osteoarticular pain: an evidence-based review. Ther Adv Musculoskelet Dis. 2(2):105-118. PMID: 21304830


Singh JA, Reddy SG, Kundukulam J. 2011. Risk factors for gout and prevention: a systematic review of the literature. Curr Opin Rheumatol. 23(2):192-202. PMID: 21285714 


Singh JA, Fitzgerald PM. 2011. Botulinum toxin for shoulder pain: a cochrane systematic review. J Rheumatol. 38(3):409-18. PMID: 21285169


Singh JA, Sperling J, Buchbinder R, McMaken K. 2011. Surgery for shoulder osteoarthritis: a cochrane systematic review. J Rheumatol. 38(4):598-605. PMID: 21239751


Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, Ghogomu ET, Tugwell P. 2010. Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Sao Paulo Med J. 128(5):309-10. PMID: 21181074


Singh JA, Lewallen DG. 2010. Predictors of activity limitation and dependence on walking aids after primary total hip arthroplasty. J Am Geriatr Soc. 58(12):2387-93. PMID: 21143444


Ramiro S, Machado P, Singh JA, Landewé RB, da Silva JA. 2010. Applying science in practice: the optimization of biological therapy in rheumatoid arthritis. Arthritis Res Ther. 12(6):220. PMID: 21067530


Singh JA. 2010. Advances in gout: some answers, more questions. Arthritis Res Ther. 12(5):136. PMID:20959031


Barsevick A, Frost M, Zwinderman A, Hall P, Halyard M; GENEQOL Consortium. 2010. I'm so tired: biological and genetic mechanisms of cancer-related fatigue. Qual Life Res. 19(10):1419-27. PMID: 20953908


Singh JA, Beg S, Lopez-Olivo MA. 2010. Tocilizumab for rheumatoid arthritis. Cochrane Database Syst Rev. 7:CD008331. PMID: 20614469


Singh JA, Lewallen D. 2010. Predictors of pain and use of pain medications following primary Total Hip Arthroplasty (THA): 5,707 THAs at 2-years and 3,289 THAs at 5-years.BMC Musculoskelet Disord. 11:90.PMID: 20462458


Singh JA, Noorbaloochi S, Singh G. 2010. Golimumab for rheumatoid arthritis: a systematic review.J Rheumatol. 37(6):1096-104.PMID: 20436075


Boon AJ, Smith J, Dahm DL, Sorenson EJ, Larson DR, Fitz-Gibbon PD, Dykstra DD, Singh JA. 2010. Efficacy of intra-articular botulinum toxin type A in painful knee osteoarthritis: a pilot study. PM R. 2(4):268-76.PMID: 20430328


Singh JA, Gabriel SE, Lewallen DG. 2010. Higher Body Mass Index Is Not Associated With Worse Pain Outcomes After Primary or Revision Total Knee Arthroplasty.J Arthroplasty. 26(3):366-374 PMID: 20413245


Anderson A, Singh JA. 2010. Pegloticase for chronic gout. Cochrane Database Syst Rev. 3:CD008335 PMID: 20238366


Singh JA, Alpert MD, Kerr G. 2010. A national survey of veterans affairs rheumatologists for relevance of quality of care indicators for gout management. Arthritis Care Res (Hoboken). [Epub ahead of print] PMID: 20235197


Singh JA, Sloan JA, Johanson NA. 2010. Challenges with health-related quality of life assessment in arthroplasty patients: problems and solutions. J Am Acad Orthop Surg. 18(2):72-82. PMID: 20118324


Strand V, Singh JA. 2010. Newer biological agents in rheumatoid arthritis: impact on health-related quality of life and productivity.Drugs. 70(2):121-45. PMID: 20108988


Singh JA, Noorbaloochi S, Singh G. 2010. Golimumab for rheumatoid arthritis. Cochrane Database Syst Rev. (1):CD008341. PMID: 20091667


Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, Ghogomu ET, Tugwell P. 2009. A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview. CMAJ. 181(11):787-96. PMID: 19884297


Singh JA, Murphy S, Bhandari M. 2009. Assessment of the methodologic quality of medical and surgical clinical trials in patients with arthroplasty. J Rheumatol. 36(12):2642-54. PMID: 19884268


Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, Tanjong Ghogomu E, Tugwell P. 2009. Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Cochrane Database Syst Rev. 7(4):CD007848. Review. PMID: 19821440


Maxwell L, Singh JA. 2009. Abatacept for rheumatoid arthritis. Cochrane Database Syst Rev. 7;(4):CD007277. Review. PMID: 19821401


Grainger R, Taylor WJ, Dalbeth N, Perez-Ruiz F, Singh JA, Waltrip RW, Schlesinger N, Evans R, Edwards NL, Sivera F, Diaz-Torne C, MacDonald PA, McQueen FM, Schumacher HR. 2009. Progress in measurement instruments for acute and chronic gout studies. J Rheumatol. 36(10):2346-55. PMID: 19820224


Schumacher HR, Taylor W, Edwards L, Grainger R, Schlesinger N, Dalbeth N, Sivera F, Singh J, Evans R, Waltrip RW, Diaz-Torne C, MacDonald P, McQueen F, Perez-Ruiz F. 2009. Outcome domains for studies of acute and chronic gout. J Rheumatol. 236(10):2342-5. PMID: 19820223


Riddle DL, Stratford PW, Singh JA, Strand CV. 2009. Variation in outcome measures in hip and knee arthroplasty clinical trials: a proposed approach to achieving consensus. J Rheumatol. 36(9):2050-6. PMID: 19738212


Singh JA, Lewallen D. 2009. Age, gender, obesity, and depression are associated with patient-related pain and function outcome after revision total hip arthroplasty. Clin Rheumatol. PMID: 19727914


Gioe TJ, Glynn J, Sembrano J, Suthers K, Santos ER, Singh J. 2009. Mobile and fixed-bearing (all-polyethylene tibial component) total knee arthroplasty designs. A prospective randomized trial. J Bone Joint Surg Am. 91(9):2104-12. PMID: 19723986


Singh JA, Murphy S, Bhandari M. 2009. Trial sample size, but not trial quality, is associated with positive study outcome. J Clin Epidemiol. PMID: 19716266

 

 

SOM Epilogue Menu